CNSP Earnings

Quarterly EPS
$-153.20
Q3 2024
$-35.38
Q4 2024
$-18.93
Q1 2025
$-6.42
Q2 2025
$-5.76
Q3 2025
$-9.65
Q4 2025
$-7.30
Q1 2026
$-0.38
Q2 2026
Latest RevenueN/A
Latest Net Income-2588000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.380-2588000—+94.1%
Q1 2026-$7.300-4937046—+61.4%
Q4 2025-$9.650-5955802—+72.7%
Q3 2025-$5.760-3218481—+96.2%
Q2 2025-$6.420-2375000—+99.8%
Q1 2025-$18.930-4301320—+99.8%
Q4 2024-$35.380-3176366—+99.9%
Q3 2024-$153.200-5605934—+99.5%
Q2 2024-$4,049.200-2530753——
Q1 2024-$12,245.760-3544748——
Q4 2023-$31,563.070-5375250——
Q3 2023-$32,484.000-4522795——
CNS Pharmaceuticals (CNSP) — Earnings